# Treatment of Resectable Malignant Brain Tumors

> **NCT00415467** · PHASE4 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Brain Tumor

## Interventions

- **DEVICE:** GliaSite Radiation Therapy System

## Key facts

- **NCT ID:** NCT00415467
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2007-11
- **Final completion:** 2008-07
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Sponsor decision to terminate study.
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00415467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00415467, "Treatment of Resectable Malignant Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00415467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*